Breaking News Instant updates and real-time market news.

MNKD

MannKind

$6.71

1.38 (25.89%)

05:56
10/11/17
10/11
05:56
10/11/17
05:56

MannKind sees Q3 net Afrezza product revenue $1.8M-$2.2M

For the three months ended September 30, MannKind expects to report $2.6M-$3.0M of gross Afrezza product revenue and $1.8M-$2.2M of net Afrezza product revenue. MannKind estimates that as of September 30, its cash and cash equivalents were approximately $20.2M. MannKind estimates that as of September 30, the principal balance outstanding for its 9.75% Senior Convertible Notes due 2019 and 8.75% Senior Convertible Notes due 2019 issued under its facility agreement with Deerfield was $60M; its 5.75% Convertible Senior Subordinated Exchange Notes Due 2018 was $27.7M; and its borrowings under the loan arrangement with The Mann Group was $79.7M. MannKind estimates that the annual purchase requirements under the insulin supply agreement with Amphastar as of September 30 were unchanged from June 30, except for the impact of foreign currency translation. MannKind said it has not yet purchased the annual minimum required quantities of insulin for 2017 of EUR 2.7M.

MNKD MannKind
$6.71

1.38 (25.89%)

10/02/17
MAXM
10/02/17
NO CHANGE
MAXM
MannKind still well-positioned to grow, says Maxim
Maxim analyst Jason Kolbert does not expect MannKind to declare bankruptcy because he does not believe that the company's main debtholders want to see that outcome, and because he thinks that its debt "can be managed." He says that over the longer term, revenue from the company's Afrezza product can enable it to overcome its debt. Kolbert keeps a $4 price target and a Buy rating on the shares.,
10/03/17
MAXM
10/03/17
NO CHANGE
MAXM
Label revision should drive MannKind sales, says Maxim
Maxim analyst Jason Kolbert says that the new label on MannKind's Afrezza drug, which includes information about its speed of delivery, "should help drive adoption" of the drug, He keeps a $4 price target and a Buy rating on the shares.
10/09/17
MAXM
10/09/17
NO CHANGE
Target $7
MAXM
Buy
MannKind price target raised to $7 from $4 at Maxim
Maxim analyst Jason Kolbert believes the FDA approval of a label revision for Afrezza translates into lower risk for the relaunch of the drug. Given the lower view of the risk, Kolbert raised his price target on MannKind shares to $7 from $4 and keeps a Buy rating on the stock.
10/10/17
HCWC
10/10/17
INITIATION
Target $7
HCWC
Buy
MannKind initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Oren Livnat started MannKind with a Buy rating and $7 price target. The shares closed yesterday up 30c to $5.33. The "game-changing" new label approved last week will allow Afrezza to gain a footing in the "very large insulin space and become the significant product that its innovation merits," Livnat tells investors in a research note. The analyst expects MannKind, under new management, to soon recapitalize and eventually accelerate Afrezza growth to peak sales more than $725M in the U.S.

TODAY'S FREE FLY STORIES

MIC

Macquarie Infrastructure

$63.62

-0.75 (-1.17%)

17:32
02/21/18
02/21
17:32
02/21/18
17:32
Hot Stocks
Macquarie Infrastructure to reduce 2018 dividend to help fund asset repurposing »

Macquarie Infrastructure…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

ILG

ILG

$32.31

0.12 (0.37%)

17:30
02/21/18
02/21
17:30
02/21/18
17:30
Hot Stocks
ILG increases quarterly dividend »

ILG announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Mar

TGB

Taseko Mines

$1.76

0.03 (1.73%)

17:28
02/21/18
02/21
17:28
02/21/18
17:28
Earnings
Taseko Mines reports Q4 adjusted EPS (C$0.01) vs. C$0.07 last year »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAND

Bandwidth

$24.09

0.18 (0.75%)

17:26
02/21/18
02/21
17:26
02/21/18
17:26
Earnings
Bandwidth sees FY18 adjusted EPS (11c)-0c, may not compare to consensus (34c) »

Sees FY18 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

BAND

Bandwidth

$24.09

0.18 (0.75%)

17:25
02/21/18
02/21
17:25
02/21/18
17:25
Earnings
Bandwidth sees Q1 adjusted EPS 7c-10c, may not compare to consensus (6c) »

Sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

SM

SM Energy

$21.30

-0.54 (-2.47%)

17:25
02/21/18
02/21
17:25
02/21/18
17:25
Hot Stocks
SM Energy sees Q1 production 9.5-10.0 MMBoe »

Sees Q1 total capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

BAND

Bandwidth

$24.09

0.18 (0.75%)

17:24
02/21/18
02/21
17:24
02/21/18
17:24
Earnings
Bandwidth reports Q4 adjusted EPS 9c, consensus 0c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

SM

SM Energy

$21.30

-0.54 (-2.47%)

17:24
02/21/18
02/21
17:24
02/21/18
17:24
Hot Stocks
SM Energy sees 2018 production 42-46 MMBoe, 41% oil »

Sees 2018 total capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

P

Pandora

$4.87

-0.46 (-8.63%)

17:24
02/21/18
02/21
17:24
02/21/18
17:24
Earnings
Pandora sees Q1 revenue $295M-$305M, consensus $322.87M »

Sees Q1 adjusted EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 23

    Feb

  • 26

    Feb

  • 05

    Mar

SM

SM Energy

$21.30

-0.54 (-2.47%)

17:23
02/21/18
02/21
17:23
02/21/18
17:23
Earnings
SM Energy reports Q4 adjusted EPS (8c), consensus (14c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

P

Pandora

$4.87

-0.46 (-8.63%)

17:22
02/21/18
02/21
17:22
02/21/18
17:22
Hot Stocks
Pandora expects FY18 top-line growth to come from subscription business »

Operating expenses will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 23

    Feb

  • 26

    Feb

  • 05

    Mar

LNCE

Snyder's-Lance

$49.90

-0.1 (-0.20%)

17:22
02/21/18
02/21
17:22
02/21/18
17:22
Hot Stocks
Snyder's-Lance initiates recall for a limited amount of Glazed Walnuts product »

Emerald Nuts, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OKE

Oneok

$56.10

-0.92 (-1.61%)

17:20
02/21/18
02/21
17:20
02/21/18
17:20
Hot Stocks
ONEOK to invest $2.3B for additional NGL, natural gas infrastructure »

ONEOK announced plans to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

GXP

Great Plains Energy

$29.45

-0.33 (-1.11%)

17:20
02/21/18
02/21
17:20
02/21/18
17:20
Earnings
Breaking Earnings news story on Great Plains Energy »

Great Plains Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

MIC

Macquarie Infrastructure

$63.62

-0.75 (-1.17%)

17:19
02/21/18
02/21
17:19
02/21/18
17:19
Hot Stocks
Breaking Hot Stocks news story on Macquarie Infrastructure »

Macquarie Infrastructure…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

MIC

Macquarie Infrastructure

$63.62

-0.75 (-1.17%)

17:19
02/21/18
02/21
17:19
02/21/18
17:19
Earnings
Macquarie Infrastructure reports Q4 EPS $4.13, may not compare to consensus 51c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

CAKE

Cheesecake Factory

$46.22

0.61 (1.34%)

17:18
02/21/18
02/21
17:18
02/21/18
17:18
Earnings
Cheesecake Factory sees FY18 EPS $2.64-$2.80, consensus $2.73 »

Sees FY18 SSS up 0%-1%.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

UTX

United Technologies

$129.26

2.8 (2.21%)

17:17
02/21/18
02/21
17:17
02/21/18
17:17
Hot Stocks
United Technologies awarded $2.5B U.S. Defense Department contract »

United Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

IAG

IAMGold

$5.86

0.07 (1.21%)

17:17
02/21/18
02/21
17:17
02/21/18
17:17
Hot Stocks
IAMGold sees 2018 attributable gold production 850K-900K oz. »

Sees 2018 CapEx $365M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

CAKE

Cheesecake Factory

$46.22

0.61 (1.34%)

17:16
02/21/18
02/21
17:16
02/21/18
17:16
Earnings
Cheesecake Factory sees Q1 EPS 66c-70c, consensus 68c »

Sees Q1 SSS up 0.5%-1.5%.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

P

Pandora

$4.87

-0.46 (-8.63%)

17:16
02/21/18
02/21
17:16
02/21/18
17:16
Hot Stocks
Breaking Hot Stocks news story on Pandora »

Pandora says Q4 mobile…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 23

    Feb

  • 26

    Feb

  • 05

    Mar

CLVS

Clovis

$54.93

1.22 (2.27%)

17:11
02/21/18
02/21
17:11
02/21/18
17:11
Hot Stocks
Clovis Oncology receives positive trend vote from CHMP for Rucaparib »

Clovis Oncology announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

HBM

Hudbay Minerals

$8.15

0.1 (1.24%)

17:10
02/21/18
02/21
17:10
02/21/18
17:10
Hot Stocks
Hudbay Minerals sees FY18 production outlook unchanged »

The company states:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

P

Pandora

$4.87

-0.46 (-8.63%)

17:10
02/21/18
02/21
17:10
02/21/18
17:10
Hot Stocks
Pandora sees significant opportunity to grow user count »

Comments from Q4 earnings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 23

    Feb

  • 26

    Feb

  • 05

    Mar

IAG

IAMGold

$5.86

0.07 (1.21%)

17:10
02/21/18
02/21
17:10
02/21/18
17:10
Earnings
IAMGold reports Q4 adjusted EPS (3c), consensus 1c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.